NK cells derived from human CD34+ hematopoietic stem and progenitor cells showed efficient infiltration and killing of human ovarian cancer spheroids using an in vivo-like model system and reduced tumor progression in mice xenografted with ovarian carcinoma (59). The gene discussed is CD34; the disease is ovarian carcinoma.